Revenue grew 30.9% to £50.0 million for the seventeen-month period, driven mainly by volume gains and strong Power Brands performance. The acquisition of FemiClear and CUROXEN provides a strategic US entry, while ongoing investments in marketing and digital transformation support future growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.